Health and Human Services Biodefense Budget Oversight
The House Appropriations Subcommittee on Labor, Health and Human Services, and Education held an oversight hearing focused on the FY2019 ...
Tag: Strategic National Stockpile
Project BioShield: HHS Purchases Anthrax Countermeasure from Elusys Therapeutics
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) will ...
U.S. Seeks to Develop Late-Stage Smallpox Antivirals
The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of ...
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development
Bavarian Nordic A/S this week updated investors on its progress for the first three quarters of 2017, highlighting MVA-BN IMVAMUNE® ...
First Shipment of ANTHIM Anthrax Treatment Delivered to Strategic National Stockpile
Elusys Therapeutics, Inc. announced today that the company has delivered the first doses of ANTHIM® (obiltoxaximab) Injection, its treatment for ...
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi
The only FDA-licensed smallpox vaccine, ACAM2000 (Smallpox (Vaccinia) Vaccine, Live), will be acquired from Sanofi by Emergent BioSolutions under a ...
CDC Stockpile Trainer Helps Other Countries Improve Supply Chain Preparedness
Tom Jackson touring proposed medical material storage site in Yaounde, Cameroon in March 2015. One of the essential goals of ...
Elusys Delivers Anthrax Countermeasure Order, Gains Funding for Lyophilization Effort
Elusys Therapeutics, Inc. has received payment from the U.S. federal government for completing the second delivery of its medical countermeasure ...
HHS Releases 2016 PHEMCE Strategy and Implementation Plan
The 2016 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan (SIP), released this week by the U.S. Department ...
CDC Awards Up to $1 Billion for BioThrax Deliveries to Strategic National Stockpile
Emergent BioSolutions Inc. this week announced that the U.S. Department of Health and Human Services (HHS) is advancing its anthrax ...
U.S. Invests in Amgen, Sanofi Countermeasures for Radiological Incidents
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is purchasing ...
BARDA Backs Biodosimetry Tests from MRIGlobal, DxTerity Diagnostics
To help save as many people as possible in the event of a large-scale nuclear or radiological emergency, the U.S. ...
NuThrax: HHS Backs Next-Gen Anthrax Vaccine with 198M Contract
The U.S. Department of Health and Human Services has awarded a new contract to Emergent Biosolutions to support advanced development ...
OrbeShield Radiation Countermeasure Gets Additional Backing
Soligenix, Inc. announced today that the Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and ...
Improving the Nation’s Medical Countermeasure Stockpile
In cases of natural or engineered disasters, such as a terrorist attack, influenza pandemic, or earthquake, state or local authorities ...
Canadian Government Orders Additional Smallpox Vaccine
The Public Health Agency of Canada (PHAC) has exercised a contract option with Bavarian Nordic A/S for the supply of ...
Spotlight on the Strategic National Stockpile
Strategic National Stockpile (SNS) storage location. Credit: CDC CDC’s Strategic National Stockpile (SNS) serves as the nation’s repository of medicines ...
Emergent Seeks Approval of Large-Scale Manufacturing of BioThrax
Emergent BioSolutions Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and ...
FDA Approves New Injection for Inhalational Anthrax
Anthrax Bacteria - Bacillus Anthracis Elusys Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Rapid Medical Countermeasure Response to Infectious Diseases
Sustaining public and private investment in the development of medical countermeasures before an emerging infectious disease becomes a public health ...
